The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting
Open Access
- 19 July 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 78 (10) , 2395-2405
Abstract
Critically ill patients have increased variability in beta-lactam antibiotic (beta-lactam) exposure due to alterations in their volume of distribution and elimination. Therapeutic drug monitoring (TDM) of beta-lactams, as a dose optimization and individualization tool, has been recommended to overcome this variability in exposure. Despite its potential benefit, only a few centres worldwide perform beta-lactam TDM. An important reason for the low uptake is that the evidence for clinical benefits of beta-lactam TDM is not well established. TDM also requires the availability of specific infrastructure, knowledge and expertise. Observational studies and systematic reviews have demonstrated that TDM leads to an improvement in achieving target concentrations, a reduction in potentially toxic concentrations and improvement of clinical and microbiological outcomes. However, a small number of randomized controlled trials have not shown a mortality benefit. Opportunities for improved study design are apparent, as existing studies are limited by their inclusion of heterogeneous patient populations, including patients that may not even have infection, small sample size, variability in the types of beta-lactams included, infections caused by highly susceptible bacteria, and varied sampling, analytical and dosing algorithm methods. Here we review the fundamentals of beta-lactam TDM in critically ill patients, the existing clinical evidence and the practical aspects involved in beta-lactam TDM implementation.Keywords
This publication has 120 references indexed in Scilit:
- Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapyCritical Care Medicine, 2012
- Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective StudyTherapeutic Drug Monitoring, 2012
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill PatientsClinical Pharmacokinetics, 2011
- Computerized provider order entry in the clinical laboratoryJournal of Pathology Informatics, 2011
- Therapeutic drug monitoring of β-lactams in critically ill patients: proof of conceptInternational Journal of Antimicrobial Agents, 2010
- High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal FunctionAntimicrobial Agents and Chemotherapy, 2010
- Prospective monitoring of cefepime in intensive care unit adult patientsCritical Care, 2010
- Pharmacokinetic issues for antibiotics in the critically ill patientCritical Care Medicine, 2009
- Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995